Focal Liver Lesion research hub

A Phase 4, Open-Label, Non-randomised, Multicentre Study to Evaluate Safety and Efficacy of Intravenous Administration of Sonazoid™ for Contrast-Enhanced Ultrasound Liver Imaging in Paediatric Patients.

This study looks at a special ultrasound scan for children with liver spots. It uses a contrast agent called Sonazoid™ to help doctors see the spots more clearly. The aim is to see how well it helps tell if these spots are harmless or need further attention.